JSH BIOTECH ApS Financials, key figures and credit report
Gross profit 194.3 kDKK FY 2024 -35.4% vs 2023
EBIT 194.3 kDKK FY 2024 -35.4% vs 2023
Net debt -3 776.0 kDKK FY 2024 -17.7% vs 2023
Quick ratio 1.4 FY 2024 +0.1 vs 2023
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 577.99 | 648.97 | 340.94 | 300.65 | 194.26 |
| EBIT | 577.99 | 648.97 | 340.94 | 300.65 | 194.26 |
| Other financial income | 3 159.72 | 3 470.29 | 1 923.94 | 43.85 | 1 040.50 |
| Other financial expenses | - 150.13 | - 228.64 | -5 519.88 | -1 726.56 | - 141.39 |
| Net income from associates (fin.) | 383.38 | 56.50 | 58.90 | 61.00 | |
| Pre-tax profit | 3 970.96 | 3 947.12 | -3 255.00 | -1 323.15 | 1 154.37 |
| Income taxes | - 789.73 | - 856.77 | |||
| Net earnings | 3 181.23 | 3 090.36 | -3 255.00 | -1 323.15 | 1 154.37 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Participating interests | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Investments total | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Non-current loans receivable | 1 023.99 | 1 023.99 | 1 525.42 | 2 124.55 | |
| Long term receivables total | 1 023.99 | 1 023.99 | 1 525.42 | 2 124.55 | |
| Inventories total | |||||
| Current trade debtors | 24.00 | 63.73 | |||
| Current owed by particip. interest comp. | 2 006.30 | 590.60 | 818.19 | 850.92 | 759.94 |
| Current other receivables | 6.28 | 1.85 | |||
| Current deferred tax assets | 171.83 | 2.69 | |||
| Short term receivables total | 2 006.30 | 614.60 | 996.30 | 855.46 | 823.66 |
| Other current investments | 7 077.32 | 8 463.00 | 4 007.60 | 3 198.81 | 3 722.29 |
| Cash and bank deposits | 55.56 | 44.96 | 1 823.56 | 8.70 | 53.73 |
| Cash and cash equivalents | 7 132.88 | 8 507.96 | 5 831.16 | 3 207.50 | 3 776.02 |
| Balance sheet total (assets) | 9 139.20 | 10 146.57 | 7 851.48 | 5 588.40 | 6 724.25 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 330.00 | 330.00 | 330.00 | 330.00 | 330.00 |
| Shares repurchased | 113.00 | 114.40 | 117.80 | 118.00 | 135.00 |
| Retained earnings | 549.04 | 3 615.87 | 6 588.43 | 3 215.43 | 1 757.27 |
| Profit of the financial year | 3 181.23 | 3 090.36 | -3 255.00 | -1 323.15 | 1 154.37 |
| Shareholders equity total | 4 173.27 | 7 150.63 | 3 781.23 | 2 340.28 | 3 376.64 |
| Non-current liabilities total | |||||
| Current trade creditors | 7.50 | 22.50 | 22.50 | 22.50 | 53.79 |
| Short-term deferred tax liabilities | 86.03 | 812.14 | |||
| Other non-interest bearing current liabilities | 4 872.40 | 2 161.30 | 4 047.75 | 3 225.63 | 3 293.82 |
| Current liabilities total | 4 965.93 | 2 995.95 | 4 070.25 | 3 248.13 | 3 347.61 |
| Balance sheet total (liabilities) | 9 139.20 | 10 146.57 | 7 851.48 | 5 588.40 | 6 724.25 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated